GOLDMAN SACHS GROUP INC - 30 Jun 2025 SCHEDULE 13G/A Report for FATE THERAPEUTICS, INC. Common Stock, par value $0.001 per share (FATE)

Filing Manager
GOLDMAN SACHS GROUP INC
Reporting Manager
THE GOLDMAN SACHS GROUP, INC.
Security
FATE THERAPEUTICS, INC. Common Stock, par value $0.001 per share
Symbol
FATE
Shares outstanding
113,701,004 shares
Disclosed Ownership
2,274,020 shares
Ownership
2%
Form type
SCHEDULE 13G/A
Filing time
14 Aug 2025, 11:30:17 UTC
Date of event
30 Jun 2025
Previous filing
09 May 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
THE GOLDMAN SACHS GROUP, INC. 2% 2,274,020 0 2,273,623 Name: Veronica Mupazviriwo Attorney-in-fact
GOLDMAN SACHS & CO. LLC 2% 2,274,020 0 2,273,623 Name: Veronica Mupazviriwo Attorney-in-fact